Immuron (IMRN) Non Operating Income (2018 - 2023)
Immuron's (IMRN) quarterly Non Operating Income came in at $149501.0 in Q4 2023, up 201.59% year-on-year from $49571.0 in Q4 2022, and up 13167.09% quarter-over-quarter from $1126.9 in Q2 2023.
Immuron (IMRN) Non Operating Income (2018 - 2023) Analysis & Trends
Immuron's Non Operating Income history runs 6 years deep, the most recent figure standing at $149501.0 for Q4 2023.
- On a quarterly basis, Non Operating Income rose 201.59% year-over-year to $149501.0 in Q4 2023; TTM through Dec 2023 was $200265.0, a 303.76% increase from a year earlier, with the FY2025 full-year figure at $83324.2, down 60.32% from the prior year.
- Non Operating Income improved to $149501.0 in Q4 2023 per IMRN's latest filing, from $1126.9 in the prior quarter.
- Across five years, Non Operating Income topped out at $149501.0 in Q4 2023 and bottomed at -$20.87 in Q4 2019.
- The 5-year median for Non Operating Income is $596.52 (2023), against an average of $33371.3.
- Across the five-year window, Non Operating Income sank 153.51% in 2019 and jumped 74793.02% in 2022, its largest moves.
- Year by year, Non Operating Income stood at -$20.87 in 2019, then increased by 22.81% to -$16.11 in 2020, then jumped by 510.86% to $66.19 in 2021, then soared by 74793.02% to $49571.0 in 2022, then jumped by 201.59% to $149501.0 in 2023.
- Per Business Quant, the three latest IMRN Non Operating Income figures stand at $149501.0 (Q4 2023), $1126.9 (Q2 2023), and $49571.0 (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Immuron | 255.19 Mn | 243.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 149,501.00 |
| Jun 30, 2023 | 1,126.86 |
| Dec 31, 2022 | 49,571.00 |
| Dec 31, 2021 | 66.19 |
| Dec 31, 2020 | -16.11 |
| Dec 31, 2019 | -20.87 |
| Dec 31, 2018 | 39.00 |